Clinical Reviewer for Linguistic Validation in Clinical Trials at 1-StopAsia

We are redirecting you to the source. If you are not redirected in 3 seconds, please click here.

Clinical Reviewer for Linguistic Validation in Clinical Trials at 1-StopAsia. Languages in Demand:. . Japanese. . Chinese Simplified. . Chinese Traditional. . Vietnamese. . Thai. . Overview:. 1StopAsia is expanding its services to include Linguistic Validation for Clinical Trials, specifically targeting the translation and assessment of Patient-Reported Outcomes (PROs) into multiple Asian languages. This emerging sector has seen a marked increase in demand. As we aim to compete in a field currently dominated by major players, we are actively seeking a specialized Clinical Reviewer (CR) to join our team.. Role:. The Clinical Reviewer will play a critical role in the linguistic validation process by ensuring the clinical accuracy and relevance of translated medical documents. This position requires a deep understanding of clinical conditions relevant to each project, and the ability to provide insightful, detailed clinical feedback on translations.. Responsibilities:. . Review translated clinical outcomes assessments and provide detailed clinical feedback.. . Participate in discussions to ensure the translated content meets the required clinical standards and relevance.. . Assist in the cognitive debriefing process by evaluating the readability and cultural appropriateness of translations.. . Contribute to the documentation process, including the Clinician Review Report.. . Ensure the integrity and clinical accuracy of the translations before final submission.. . . Native speakers of the target language. . Must reside in the country of translation. . Doctors, psychologists, psychiatrists, or clinical psychologists. . Ideally familiar with neuropsychiatry, Alzheimer’s, or dementia domains. . Must be comfortable working in English-language review files (Excel). . Excellent communication skills and attention to detail.. . Company Location: Japan.